Cargando…
Efficacy of rintatolimod in the treatment of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)
Chronic fatigue syndrome/ Myalgic encephalomyelitis (CFS/ME) is a poorly understood seriously debilitating disorder in which disabling fatigue is an universal symptom in combination with a variety of variable symptoms. The only drug in advanced clinical development is rintatolimod, a mismatched doub...
Autor principal: | Mitchell, William M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917909/ https://www.ncbi.nlm.nih.gov/pubmed/27045557 http://dx.doi.org/10.1586/17512433.2016.1172960 |
Ejemplares similares
-
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): An Overview
por: Deumer, Undine-Sophie, et al.
Publicado: (2021) -
Immunosignature Analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
por: Günther, Oliver P., et al.
Publicado: (2018) -
The Neuroinflammatory Etiopathology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
por: Glassford, Julian A. G.
Publicado: (2017) -
The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)
por: König, Rahel S., et al.
Publicado: (2022) -
How Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Progresses: The Natural History of ME/CFS
por: Nacul, Luis, et al.
Publicado: (2020)